China’s biotech and pharma giant Tasly Holding Group has announced a 500 million yuan ($75.6 million) investment into biotech company Puyuan Miaosheng Group’s industrial hemp subsidiary. The investment will be used to develop Yunnan Maye Biotech’s operations in hemp farming, foods and beverages, pet food, new tobacco products and vaporizers, and biopharmaceutical products in five … Continue reading Report: Chinese hemp company lands $75 million investment from pharma giant